Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
21.04
+1.34 (6.80%)
Aug 21, 2026, 4:08 PM HKT
HKG:2190 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, HKG:2190 stock has a consensus rating of "Strong Buy" and an average price target of $31.61. The average 1-year stock price forecast is 50.24% higher than the current stock price, while the lowest is $29.86 (+41.92%) and the highest is $33.01 (+56.89%).
Price Target: $31.61 (+50.24%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Mar 28, 2026.
Analyst Ratings
The average analyst rating for HKG:2190 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $29.65 | Buy | Maintains | $29.65 | +40.92% | Mar 28, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $29.00 | Buy | Maintains | $29.00 | +37.83% | Mar 26, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $32.00 | Buy | Maintains | $32.00 | +52.09% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
1.47B
from 1.06B
Increased by 39.16%
Revenue Next Year
1.91B
from 1.47B
Increased by 29.94%
EPS This Year
1.05
from 0.84
Increased by 24.04%
EPS Next Year
1.35
from 1.05
Increased by 28.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.